theguardian.com/world/2020/jun…
nejm.org/doi/full/10.10…
The U Minnesota researchers recruited 821 participants, 719 of whom were recently exposed to someone with CV19.
/1
The participants were randomly assigned to receive either HQC or a vitamin placebo.
/2
/3
The HQC group saw a small, but not statistically significant improvement over the control group.
/4
/5
In studies like these there is a null hypothesis, and an alternative hypothesis. In this study the null hypothesis was that HCQ has no impact on symptoms.
/6
The slight (2.4%) mean improvement for HCQ group was not enough to reject the null hypothesis at 95% confidence level, which is a standard for these thing.
/7
In short, a small improvement, but there is a 35% prob that could have resulted by chance.
/8
/9
/10
Without belaboring this, the results of the UM study also had a high probability of Type II error. It in no way "proved" that HCQ had no impact.
If you think HCQ has no impact on COVID symptoms, or if you think it has a small but positive impact on COVID symptoms, these results aren't strong enough to conclude you're wrong.
/12
/fin